RxDoctor Payments Data

Jose Trani, MD

Vascular Surgery · Seattle, WANPI 1750544599

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Cook Incorporated at 45.2% of the total. Reporting peaked in 2021 at $6,377 and has fallen 88.0% since, to $765 in 2025.

$12,811in general payments, 2019–2025

Across 91 payments — averaging $140.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$6K
  • Cook Medical LLC$3K
  • W. L. Gore & Associates, Inc.$2K
  • Silk Road Medical, Inc.$1K
  • Medtronic$355
  • Boston Scientific$257
  • plus $560 from 12 others
$31,638in research payments, 2019–2025

Across 4 payments — averaging $7909.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$32K

What the payments were for

  • Speaking & faculty fees$5,77545%
  • Travel & lodging$2,19517%
  • Food & beverage$4,84138%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,811 in reported general payments places this provider in the 80th percentile of 111 vascular surgery providers in Washington.

See all vascular surgery providers in Washington

Medicare billing

Part B allowed, 2024
$236,051
Medicare patients
581
Services billed
1,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$13,573
ClopidogrelClopidogrel Bisulfate67$455
Oxycodone Hcl40$168
Gabapentin12$140
Rosuvastatin Calcium11$48

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →